University of Houston: Expanding Gene Therapy For Rare Disease That Causes Blindness
January 20, 2023
January 20, 2023
HOUSTON, Texas, Jan. 20 (TNSfund) -- The University of Houston issued the following news release:
A University of Houston researcher is expanding a method of gene therapy with the hopes it will restore vision loss in Usher Syndrome Type 2A (USH2A), a rare genetic disease. The National Eye Institute has awarded Muna Naash, John S. Dunn Endowed Professor of biomedical engineering, $1.6 million to support her work.
Usher Syndrome Type 2A, caused by mutations of the USH2A g . . .
A University of Houston researcher is expanding a method of gene therapy with the hopes it will restore vision loss in Usher Syndrome Type 2A (USH2A), a rare genetic disease. The National Eye Institute has awarded Muna Naash, John S. Dunn Endowed Professor of biomedical engineering, $1.6 million to support her work.
Usher Syndrome Type 2A, caused by mutations of the USH2A g . . .